Lindsey Crowley

Brain penetration and efficacy of tepotinib in orthotopic patient-derived xenograft models of MET-driven non-small cell lung cancer brain metastases

Hong Zhang, C. Stroh, O. Bogatyrova, 2021, Lung Cancer.

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.

M. S. Merrill, E. Winer, E. Cerami, 2019, JCO precision oncology.

Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers.

T. E. Richardson, F. Rohdich, B. Huck, 2021, Journal of medicinal chemistry.

Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 Biology.

M. Nowak, S. Minguzzi, M. Król, 2021, Journal of medicinal chemistry.

MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models

B. Elenbaas, D. Hochhauser, J. Hartley, 2018, Oncotarget.

p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab

M. Yasunaga, H. Zhang, T. Yoshino, 2023, Scientific reports.